The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of an intravenous formulation of NEPA, a fixed combination of fosnetupitant and palonosetron, compared with oral NEPA studies in the prevention of chemotherapy-induced nausea and vomiting (CINV): An analysis of 1026 patient experiences.
 
Eric Roeland
Honoraria - Pfizer
Consulting or Advisory Role - AIM Specialty Health; Helsinn Healthcare (Inst); HERON; Napo Pharmaceuticals; Oragenics; Pronova (Inst)
Speakers' Bureau - Depomed; Eisai
Research Funding - AstraZeneca (Inst); XBiotech (Inst)
 
Paul Joseph Hesketh
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Boehringer Ingelheim; MSD
 
Richard J. Gralla
Honoraria - Chugai Pharma; Helsinn Healthcare; Merck; Mundipharma
Consulting or Advisory Role - Helsinn Healthcare
Research Funding - Merck
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro